Gibot Sébastien
Service de Réanimation Médicale, Hôpital Central, Nancy Cedex, France.
Semin Respir Crit Care Med. 2006 Feb;27(1):29-33. doi: 10.1055/s-2006-933671.
The triggering receptor expressed on myeloid cells (TREM)-1 is a recently identified molecule involved in the inflammatory response. It belongs to the immunoglobulin superfamily and is expressed on the surface of neutrophils, mature monocytes, and macrophages. The engagement of TREM-1 synergizes with the Toll-like receptors signaling pathway in amplifying the inflammatory response mediated by several microbial components. The expression of the membrane-bound TREM-1 is strongly upregulated on monocytes during sepsis. Besides its membranous form, a soluble counterpart of TREM-1 exists that is specifically released during several infectious processes. The measurement of that soluble form in biological fluids may be useful as a diagnostic tool, especially during severe sepsis and pneumonia. Moreover, the evolutionary pattern of TREM-1 may be interesting during the follow-up of septic patients.
髓系细胞触发受体(TREM)-1是最近发现的参与炎症反应的分子。它属于免疫球蛋白超家族,在中性粒细胞、成熟单核细胞和巨噬细胞表面表达。TREM-1的激活与Toll样受体信号通路协同作用,放大由多种微生物成分介导的炎症反应。脓毒症期间,单核细胞表面膜结合型TREM-1的表达强烈上调。除了膜结合形式,TREM-1还存在可溶性对应物,在多种感染过程中特异性释放。检测生物体液中该可溶性形式可能作为一种诊断工具,尤其在严重脓毒症和肺炎期间。此外,在脓毒症患者的随访过程中,TREM-1的进化模式可能会很有意思。